» Authors » Mark Nuppnau

Mark Nuppnau

Explore the profile of Mark Nuppnau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 26
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rojas J, Lyons P, Chhikara K, Chaudhari V, Bhavani S, Nour M, et al.
Intensive Care Med . 2025 Mar; PMID: 40080116
Rationale: Critical illness threatens millions of lives annually. Electronic health record (EHR) data are a source of granular information that could generate crucial insights into the nature and optimal treatment...
2.
Chang T, Nuppnau M, He Y, Kocher K, Valley T, Sjoding M, et al.
PLOS Glob Public Health . 2024 Oct; 4(10):e0003555. PMID: 39475953
AI models are often trained using available laboratory test results. Racial differences in laboratory testing may bias AI models for clinical decision support, amplifying existing inequities. This study aims to...
3.
Rojas J, Lyons P, Chhikara K, Chaudhari V, Bhavani S, Nour M, et al.
medRxiv . 2024 Sep; PMID: 39281737
Background: Critical illness, or acute organ failure requiring life support, threatens over five million American lives annually. Electronic health record (EHR) data are a source of granular information that could...
4.
Chanderraj R, Admon A, He Y, Nuppnau M, Albin O, Prescott H, et al.
JAMA Intern Med . 2024 May; 184(7):769-777. PMID: 38739397
Importance: Experimental and observational studies have suggested that empirical treatment for bacterial sepsis with antianaerobic antibiotics (eg, piperacillin-tazobactam) is associated with adverse outcomes compared with anaerobe-sparing antibiotics (eg, cefepime). However,...
5.
McCallister R, Nuppnau M, Sjoding M, Dickson R, Chanderraj R
Chest . 2023 Apr; 164(3):667-669. PMID: 37087051
No abstract available.
6.
Andrist E, Nuppnau M, Barbaro R, Valley T, Sjoding M
JAMA Netw Open . 2022 Mar; 5(3):e224584. PMID: 35357460
No abstract available.